AUG 16, 2017 06:34 PM PDT
Molecular Band-Aid Repairs Heart Muscle Tissue
WRITTEN BY: Kara Marker
3 7 383

Heart attack patients can be given regenerative tissue to help them recover, but the current procedure involves open-heart surgery, which is risky for individuals whose hearts are already under duress. From the University of Toronto Faculty of Applied Science & Engineering, scientists offer another solution.

The flexible tissue scaffold, shown here emerging from a glass pipette with a tip one millimetre wide, unfolds itself after injection into the body. This could enable surgeons to use minimally invasive techniques, which reduce recovery time, scarring and other negative effects. Credit: Miles Montgomery and Rick Lu

Researchers with expertise in growing human tissue on “polymer scaffolds” present a biocompatible, biodegradable patch of heart tissue that can be delivered to the heart via a small needle, no massive surgery required. The technology is so close to real tissue that scientists are already using the patches to test drug candidates for side effects. The development of this patch comes from years of troubleshooting and optimizing cells to perfectly complement the target tissue in the heart.

"If an implant requires open-heart surgery, it's not going to be widely available to patients," explained Toronto professor Milica Radisic. Heart attack and other disease states leave the heart so vulnerable that an invasive procedure, even one intended to fix the brokenness, is more risky than it is helpful. This is what drove the search for a treatment that could be injected instead of implanted through open-heart surgery.

Radisic and her team are calling the new technology “AngioChip.” The heart patch has its own blood supply via vessels, and it unfolds into just the right shape after injection.

The key obstacles Radisic faced during the development of AngioChip were the mechanical properties and “shape-memory behavior” needed for the patch to successfully integrate itself into the heart tissue. Once they were able to ensure the patch had the right mix of these qualities, they could create a patch that needed a one-time only injection and that wouldn’t be altered by other factors at the injection site.

They grew the patch with other heart cells and successfully injected it into rat and pig models. AngioChip proved to be just as efficient and safe as delivering a similar treatment via surgery. Even more, the patch showed the ability to improve cardiac function; researchers observed more efficient ventricle pumping after its injection.

"When we saw that the lab-grown cardiac tissue was functional and not affected by the injection process, that was very exciting," explained Miles Montgomery, a PhD student in the lab who spent three years tweaking and optimizing the new technology. "Heart cells are extremely sensitive, so if we can do it with them, we can likely do it with other tissues as well."

Montgomery and Radisic believe that the same approach that resulted in the AngioChip could be used to treat other diseases. With growth factors and drugs, the technology is customizable to fit other organs for other purposes.

Going forward Radisic and the team plan on optimizing the patch’s long-term stability, maintenance of improved cardiac function, and potential use in other organs. Besides heart disease, what kinds of conditions could this technology treat?

The present study is published in the journal Nature Materials.

Source: University of Toronto Faculty of Applied Science & Engineering

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JAN 20, 2018
Cardiology
JAN 20, 2018
Nitric Oxide Treats Heart Attack, Asthma, and Impotence
One small molecule called nitric oxide (NO) plays so many different roles in the cell, valuable and destructive. Scientists from Case Western Reserve Unive
JAN 29, 2018
Cardiology
JAN 29, 2018
Mesp1 Gene Activity Linked to Congenital Heart Defects
Early during development as the embryo begins to form, the heart is the first organ to materialize. So-called “progenitor” cells hold the key t
FEB 14, 2018
Cardiology
FEB 14, 2018
Breathing Life Back Into Diseased Heart Cells
A dangerous yet inevitable part of heart disease is the replacement of healthy heart muscle cells with scar tissue. In an effort to combat heart disease, s
FEB 21, 2018
Cardiology
FEB 21, 2018
How a Heart Attack Affects the Kidneys
The inflammatory response following a heart attack affects another organ too: the kidneys. From the University of Alabama at Birmingham, scientists investi
MAR 09, 2018
Cardiology
MAR 09, 2018
Childhood Cancer Survivors Face Heart Disease Later in Life
Children who survive cancer are at an increased risk for heart disease in later in life, often developing heart disease nearly a decade before the average
MAR 16, 2018
Cardiology
MAR 16, 2018
Four RNA Molecules that Predict an Irregular Heartbeat
Atrial fibrillation (AF), an irregular heartbeat, often goes unnoticed until the affected person has a stroke. Scientists are interested in identifying a b
Loading Comments...